비즈니스 · 2002. 4. 17.1 분 읽기
Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEPREX; Extension of Comment Period
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is extending to April 26, 2002, the comment period for the regulatory review period determination for MIFEPREX, published in the Federal Register of January 25, 2002 (67 FR 3724). The agency is taking this action in response to a request for an extension.